-
Access to HealthcareFighting malaria in AfricaThe head of Public Affairs for the Novartis Malaria Initiative has a malaria story of her own to tell.
Access to Healthcare -
Patient PerspectivesProtecting our tomorrows: Portraits of Meningococcal DiseaseTo raise awareness of the sudden and profound impact of meningococcal disease on families across the globe, world-renowned photographer Anne Geddes has joined forces with the Confederation of Meningitis Organizations (CoMO) and Novartis Vaccines and Diagnostics for the Protecting Our Tomorrows: Portraits of Meningococcal Disease project.
Patient Perspectives -
From Our LabsYoung talent & emerging technologies come together at BioCampUniversity students majoring in the life sciences or business often have trouble imagining the direction of their careers.
From Our Labs -
From Our LabsDisease pathways: A key to new drug discoveryUsing new technologies, researchers have developed a deeper understanding of how cells function, changing conceptions of disease.
From Our Labs -
DiscoveryTackling a rare disease: Working toward a treatment for SMAMost people have never heard of spinal muscular atrophy (SMA), a rare genetic disease that affects approximately 1 in 6,000 babies born worldwide each year. Innovative research may produce treatments for patients suffering from SMA and other rare diseases.
Discovery -
Access to HealthcareMaking healthcare sustainable in the developing worldToday, many companies are trying to solve global health challenges through philanthropy. However, it has become clear that philanthropy alone is no longer enough to make a lasting impact.
Access to Healthcare -
From Our LabsSurfing the wave of big data analyticsThe cause of a rare, inherited, often fatal kidney disease in many patients remained elusive for years, despite multiple attempts to solve the mystery. Then in 2012, a team of researchers cracked some of the unsolved cases in just six weeks.
From Our Labs -
DiscoveryPhysician-Scientist Donald Ganem takes the reins in Infectious DiseaseDiscovery